A big blow for relations between Indian drugmaker and its global partners has come out after Biocon-Pfizer divorced their joint partnership.
Pfizer is the world’s largest U.S. drugmaker has ended a deal to sell insulin products produced by Biocon Ltd (BION.NS), India’s biggest biotech company due to the individual priorities and threat of intellectual property protection in such countries.
Pfizer- Biocon jointly revealed a statement on Tuesday, “The companies have agreed that due to the individual priorities for their respective biosimilars businesses of insulin and insulin analog products, it is in their best interest to move forward independently.” Read more
